logo
Menu

This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Drugs > Sacubitril/valsartan for the treatment of post-acute myocardial infarction patients with left ventricular systolic dysfucntion and/or pulmonary congestion – first line

< Back

Sacubitril/valsartan for the treatment of post-acute myocardial infarction patients with left ventricular systolic dysfucntion and/or pulmonary congestion – first line

Drugs

Cardiovascular Disease and Vascular Surgery

April 2021


Sacubitril/valsartan is currently in clinical development for the treatment of patients who have suffered a heart attack (acute myocardial infarction (AMI), and who have evidence of left ventricular systolic dysfunction (LVSD) and/or pulmonary congestion. LVSD means that the heart muscle does not contract effectively and therefore, less oxygen-rich blood is pumped out to the rest of the body. Patients who develop LVSD following an AMI have a higher risk of complications and sudden cardiac death. There remains a large unmet need for new therapies for these patients.
Sacubitril/valsartan is a dual combination drug targeting the RAAS and neprilysin systems. It is given orally in the form of a tablet. It contains two different active ingredients sacubitril and valsartan, that work independently to reduce blood pressure, protect the heart from developing scar tissue and reduce the strain on the heart. If licensed, sacubitril/valsartan may offer an additional treatment option for post-acute AMI patients with evidence of LVSD and/or pulmonary congestion.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment

Download Full Article



 

Connect to the Innovation Observatory

Twitter

Load More Related Posts

Get Alerts